GUGGENHEIM CAPITAL LLC - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 123 filers reported holding XENON PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$380,269
-4.8%
11,132
+7.3%
0.00%0.0%
Q2 2023$399,399
-41.9%
10,374
-46.0%
0.00%
-50.0%
Q1 2023$687,955
-8.6%
19,222
+0.7%
0.01%
-14.3%
Q4 2022$752,837
+39.7%
19,093
+27.8%
0.01%
+40.0%
Q3 2022$539,000
+23.3%
14,938
+3.9%
0.01%
+66.7%
Q2 2022$437,000
+0.7%
14,377
+1.3%
0.00%0.0%
Q1 2022$434,000
+1.6%
14,193
+3.7%
0.00%
+50.0%
Q4 2021$427,000
+177.3%
13,684
+35.8%
0.00%
+100.0%
Q3 2021$154,00010,0750.00%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 790,000$12,071,0003.53%
GREAT POINT PARTNERS LLC 700,000$10,696,0002.49%
COMMODORE CAPITAL LP 579,432$8,854,0002.33%
ACUTA CAPITAL PARTNERS, LLC 417,409$6,378,0002.25%
DAFNA Capital Management LLC 406,535$6,212,0001.65%
Tri Locum Partners LP 264,134$4,036,0001.60%
Parkman Healthcare Partners LLC 311,207$4,755,0001.20%
Ghost Tree Capital, LLC 250,000$3,820,0001.12%
Nan Fung Group Holdings Ltd 197,880$3,024,0000.97%
BVF INC/IL 1,571,778$24,017,0000.94%
View complete list of XENON PHARMACEUTICALS INC shareholders